Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different dose amoxicillin + vonoprazan dual therapy for H. pylori eradication in elderly patients
ChiCTR2500104790Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin and vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Eradication rate. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
amoxicillinvonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500104790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104790.